CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
CANNAPHARMARX, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.36M
- P/E (TTM)
- –
- Dividend yield
- –
Cannapharmarx statistics
Financials through Jun 30, 2026, price as of Oct 16, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Market Cap | $1.42M | $166.30M |
| Enterprise Value | $1.42M | $87.12M |
| PS Ratio | 0.83 | 3.60 |
Enterprise value
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| EV / Sales | 0.83 | 2.43 |
Income (trailing twelve months)
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Revenue | $1.70M | $57.94M |
| Gross Profit | -$1.51M | $90.47M |
| Operating Income | -$2.89M | -$21.49M |
| Net Income | -$11.32M | -$22.46M |
| EBITDA | -$2.89M | -$17.14M |
Margins
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Gross Margin | -88.8% | 52.3% |
| Operating Margin | -170.1% | -44.5% |
| Profit Margin | -666.2% | -39.2% |
| EBITDA Margin | -170.1% | -31.3% |
Returns
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Return on Assets (ROA) | -123.3% | -41.0% |
Growth
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 24.8% | 6.01% |
Balance sheet
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $555 | $62.64M |
| Net Cash (Debt) | $555 | $15.77M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$30.83M | $48.61M |
| Book Value Per Share | -$0.04 | $1.36 |
| Tangible Book Value | -$30.83M | $23.01M |
| Working Capital | -$31.24M | $75.09M |
Financial position
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Current Ratio | 0.04 | 3.30 |
| Quick Ratio | 0.00 | 2.39 |
| Interest Coverage | -1.91 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Operating Cash Flow | -$112.28K | -$12.39M |
Efficiency
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Asset Turnover | 0.19 | 0.38 |
| Inventory Turnover | 2.73 | 2.67 |
| Revenue Per Employee | $65.34K | $398.96K |
| Profits Per Employee | -$435.33K | -$705.27K |
| Employee Count | 26 | 74 |
Dividends and yields
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Earnings Yield | -798.5% | -22.8% |
Shares
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Shares Outstanding | 708,690,000 | 58,139,000 |
| Shares Change (QoQ) | 4.45% | 0.54% |
| Float | 685,322,000 | 49,154,900 |
| Shares Held by Insiders | 3.30% | 11.6% |
Scores
| Measure | Cannapharmarx | Industry median |
|---|---|---|
| Altman Z-Score | -29.83 | -0.27 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Cannapharmarx's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.